Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - LORD JONATHAN T MD
Last Updated 
13-Nov-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

LORD JONATHAN T MD: Declared Holdings
Company/RelationshipReportedShares  Ownership
Biolase, Inc.
Director
NasdaqCM:BIOL
(historical quotes, profile, other insiders)
3-Nov-14101,163  Direct
DexCom, Inc.
Director
NasdaqGS:DXCM
(historical quotes, profile, other insiders)
11-Nov-14137,107  Direct
Stericycle, Inc.
Director
NasdaqGS:SRCL
(historical quotes, profile, SEC, other insiders)
28-Jun-13100  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
11-Nov-14 18,058DXCM Option Exercise at $7.78 per share.
(Cost of $140,491)
11-Nov-14 18,058DXCM Sale at $53.09 per share.
(Proceeds of $958,699)
3-Nov-14 101,163BIOL Purchase at $2.39 per share.
(Cost of $241,779)
26-Aug-14 20,000DXCM Sale at $45.56 per share.
(Proceeds of $911,200)
26-Aug-14 20,000DXCM Option Exercise at $7.78 per share.
(Cost of $155,600)
30-May-14 8,797DXCM Acquisition (Non Open Market) at $0 per share.
13-Mar-14 36,000DXCM Sale at $45.05 per share.
(Proceeds of $1,621,800)
13-Mar-14 36,000DXCM Option Exercise at $7.78 per share.
(Cost of $280,080)
25-Feb-14 64,807DXCM Sale at $45.15 per share.
(Proceeds of $2,926,036)
25-Feb-14 64,807DXCM Option Exercise at $4.58 per share.
(Cost of $296,816)
28-Jun-13 6,040SRCL Option Exercise at $23.59 per share.
(Cost of $142,483)
28-Jun-13 6,040SRCL Sale at $110 per share.
(Proceeds of $664,400)
31-May-13 15,079DXCM Acquisition (Non Open Market) at $0 per share.


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?